| Alternative name1 | Anti-Goat anti-PAI1 / SERPINE1 Antibody |
| Alternative name2 | Anti-, Caprine anti-PAI1 / SERPINE1 |
| Alternative name3 | Caprinae anti-PAI1 / SERPINE1 Antibody |
| Alternative name4 | PAI1/SERPINE1 |
| Alternative name5 | PAI, PAI, PAI-1, PAI-1, PAI1, PAI1, PLANH1, PLANH1, SERPINE1, clade E (nexin, clade E (nexin, clade E (nexin, clade E (nexin, member 1, member 1, member 1, member 1, plasminogen activator inhibitor, plasminogen activator inhibitor, plasminogen activator inhibitor type 1), plasminogen activator inhibitor type 1), plasminogen activator inhibitor type 1), plasminogen activator inhibitor type 1), plasminogen activator inhibitor-1, plasminogen activator inhibitor-1, serine (or cysteine) proteinase inhibitor, serine (or cysteine) proteinase inhibitor, serpin peptidase inhibitor, serpin peptidase inhibitor, type I, type I, SERPINE1 |
| Other names | Endothelial plasminogen activator inhibitor, Plasminogen activator inhibitor 1, Serpin E1, clade E (nexin, clade E (nexin, endothelial plasminogen activator inhibitor, member 1, member 1, plasminogen activator inhibitor 1, plasminogen activator inhibitor type 1), plasminogen activator inhibitor type 1), serine (or cysteine) proteinase inhibitor, serpin E1, serpin peptidase inhibitor, plasminogen activator inhibitor 1 |
| Gene name | SERPINE1 |
| Gene name synonims | N/A |
| Other gene names | PAI, PAI, PAI-1, PAI-1, PAI1, PAI1, PLANH1, PLANH1, SERPINE1, SERPINE1 |
| Category | Antibodies |
| Clonality | Polyclonal |
| Immunoglobulin isotype | N/A |
| Clone | Polyclonal antibody |
| Host organism | Goat |
| Species reactivity | Dog, Human |
| Specificity and cross-reactivity | N/A |
| Purification method | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide |
| Form/Appearance | 0, pH7, 02% sodium azide, 3 with 0, 5 mg/ml in Tris saline, 5% bovine serum albumin, Supplied at 0, _x000D_ |
| Concentration | 100ug specific antibody in 200ul |
| Storage and shipping | Cycles of freezing and thawing should be avoided as they may damage the polypeptide chains thus reducing the activity of the antibody, After been aliquoted the antibody should be stored at -20 degrees Celsius |
| Tested for: | ELISA (EIA), Immunohistochemistry (IHC), Western Blot (WB), Peptide ELISA (EIA) |
| Description | Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Advisory | For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Latin name | Capra aegagrus hircus |
| Gene target | PAI1 / SERPINE1 |
| Short name | Goat anti-PAI1 / SERPINE1 Antibody |
| Technique | antibodies against human proteins, antibodies for, antibody to, goats, Antibody |
| Host | It are very good secondary antibodies that are affinity purified and have a good affinity themselves too, Often KLH is coupled to the antigen so anti KLH can be present in the vial, The goat polyclonal antibodies are directed against human genes or rabbit or mouse IgGs (H +L) chain primary antibodies and conjugated for detection, Goat |
| Species | Goats |
| Alternative name | clade E (nexin, member 1 (Antibody to), plasminogen activator inhibitor classification 1), caprine antibody to-PAI1 / serpin peptidase inhibitor |
| Alternative technique | antibodies |
| Alternative to gene target | DNA-templated and biological process this GO :0006367 and transcription initiation from RNA polymerase II promoter and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007596 and blood coagulation and biological process this GO :0010467 and gene expression and biological process this GO :0010469 and regulation of receptor activity and biological process this GO :0010757 and negative regulation of plasminogen activation and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0014912 and negative regulation of smooth muscle cell migration and biological process this GO :0030168 and platelet activation and biological process this GO :0030194 and positive regulation of blood coagulation and biological process this GO :0030195 and negative regulation of blood coagulation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031093 and platelet alpha granule lumen and cellular component this GO :0032757 and positive regulation of interleukin-8 production and biological process this GO :0033629 and negative regulation of cell adhesion mediated by integrin and biological process this GO :0035491 and positive regulation of leukotriene production involved in inflammatory response and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042730 and fibrinolysis and biological process this GO :0045087 and innate immune response and biological process this GO :0045765 and regulation of angiogenesis and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048260 and positive regulation of receptor-mediated endocytosis and biological process this GO :0050729 and positive regulation of inflammatory response and biological process this GO :0050829 and defense response to Gram-negative bacterium and biological process this GO :0051918 and negative regulation of fibrinolysis and biological process this GO :0061044 and negative regulation of vascular wound healing and biological process this GO :0061045 and negative regulation of wound healing and biological process this GO :0071222 and cellular response to lipopolysaccharide and biological process this GO :0090026 and positive regulation of monocyte chemotaxis and biological process this GO :1902042 and negative regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :2000098 and negative regulation of smooth muscle cell-matrix adhesion and biological process this GO :2000352 and negative regulation of endothelial cell apoptotic process and biological process, Extracellular, PAI and PAI-1 and PAI1 and PLANH1, SERPINE1 and IDBG-32959 and ENSG00000106366 and 5054, SERPINE1 and IDBG-640415 and ENSBTAG00000014465 and 281375, Serpine1 and IDBG-204786 and ENSMUSG00000037411 and 18787, clade E (nexin, member 1, plasminogen activator inhibitor type 1), protein binding, this GO :0001300 and chronological cell aging and biological process this GO :0001525 and angiogenesis and biological process this GO :0002020 and protease binding and molecular function this GO :0002576 and platelet degranulation and biological process this GO :0004867 and serine-type endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006351 and transcription, this GO :0002020: protease binding, this GO :0002020: protease binding and also this GO :0004867: serine-type endopeptidase inhibitor activity and also this GO :0005102: receptor binding and also this GO :0005515: protein binding, this GO :0004867: serine-type endopeptidase inhibitor activity, this GO :0005102: receptor binding, this GO :0005515: protein binding, serpin peptidase inhibitor |
| Identity | 8583 |
| Gene | SERPINE1 |
| Long gene name | serpin family E member 1 |
| Synonyms gene | PLANH1 PAI1 |
| Synonyms gene name | clade E (nexin, clade E (nexin, member 1 , member 1 serpin peptidase inhibitor, plasminogen activator inhibitor type 1), plasminogen activator inhibitor type 1), serine (or cysteine) proteinase inhibitor |
| Synonyms | PAI |
| Synonyms name | plasminogen activator inhibitor, type I |
| Locus | 7q22, 1 |
| Discovery year | 1986-01-01 |
| GenBank acession | M16006 |
| Entrez gene record | 5054 |
| Pubmed identfication | 3097076 2891140 24172014 |
| RefSeq identity | NM_000602 |
| Classification | Serpin peptidase inhibitors |
| Havana BLAST/BLAT | OTTHUMG00000157107 |
| Locus Specific Databases | LRG_597 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue